HIMSS Media's newest member will be discussing one of digital health's more popular markets during a special breakfast at next week's mHealth Summit.
"Digital Health's Disruption of Pharma," presented by MobiHealthNews, will take place from 7-8:30 a.m. Tuesday, Nov. 10, in National Harbor 10-11. MobiHealthNews Editor-in-Chief Brian Dolan will moderate a panel that features Jane Rhodes, senior director of new initiatives at Biogen's Innovatin Hub; Drew Schiller, co-founder and chief technology officer for Validic (the event's sponsor); and Joe Dustin, a consultant for Medidata Solutions.
For more information and to register for this add-on event, click here.
[Learn more about the 2015 mHealth Summit.]
"Digital health's impact on pharma is only just beginning to be explored," the event's organizers say in a description of the breakfast topic. "Connected health technologies are providing new opportunities for data to be leveraged in clinical studies, remote monitoring and drug-device combination therapies. Across the drug development continuum, data is key at every phase, including participant recruitment."
"Digital health presents a unique opportunity to help pharma and their research partners maximize efficiency of getting a drug to market by driving speed and reducing costs," the organizers continue. "These sensors, wearables and applications are also being used to help remedy key issues plaguing the healthcare system, such as medication adherence and compliance."
The mHealth Summit, part of the HIMSS Connected Health Conference, takes place Nov. 8-11 at the Gaylord National Resort and Convention Center in Winter Harbor, Md., just outside Washington D.C. For more information on the mHealth Summit or the co-located Cybersecurity Summit and Population Health Summit, visit the conference website.